Key result
Machine learning predicts abnormal myocardial perfusion better than the clinical CAD consortium model with ~0.76 AUC.
Why the study?
Accurately predicting abnormal perfusion on MPI using pre-test clinical features may help physicians guide non-invasive test selection decisions.
Does a machine learning model using pre-test clinical features improve prediction of abnormal myocardial perfusion compared to traditional CAD risk models in patients undergoing SPECT MPI?
Observational (n=29,437)
Yes
Does a machine learning model using pre-test clinical features improve prediction of abnormal myocardial perfusion compared to traditional CAD risk models in patients undergoing SPECT MPI?
A machine learning algorithm using routine pre-test clinical data can more accurately predict abnormal myocardial perfusion than standard risk scores, potentially optimizing non-invasive test selection.
Answers are grounded in this paper and cite their sources.
ML may enhance pre-test perfusion prediction; hypothesis-generating and should not yet change practice.
BACKGROUND: Accurately predicting which patients will have abnormal perfusion on MPI based on pre-test clinical information may help physicians make test selection decisions. We developed and validated a machine learning (ML) model for predicting abnormal perfusion using pre-test features. METHODS: We included consecutive patients who underwent SPECT MPI, with 20,418 patients from a multi-center (5 sites) international registry in the training population and 9019 patients (from 2 separate sites) in the external testing population. The ML (extreme gradient boosting) model utilized 30 pre-test features to predict the presence of abnormal myocardial perfusion by expert visual interpretation. RESULTS: In external testing, the ML model had higher prediction performance for abnormal perfusion (area under receiver-operating characteristic curve [AUC] 0.762, 95% CI 0.750-0.774) compared to the clinical CAD consortium (AUC 0.689) basic CAD consortium (AUC 0.657), and updated Diamond-Forrester models (AUC 0.658, p < 0.001 for all). Calibration (validation of the continuous risk prediction) was superior for the ML model (Brier score 0.149) compared to the other models (Brier score 0.165 to 0.198, all p < 0.001). CONCLUSION: ML can predict abnormal myocardial perfusion using readily available pre-test information. This model could be used to help guide physician decisions regarding non-invasive test selection.
No takes yet. Share an insight, caveat, or question.
Miller et al. (2022) conducted an observational in Patients undergoing SPECT MPI for suspected or known coronary artery disease (n=29,437). Machine learning (XGBoost) model utilizing 30 pre-test features vs. Clinical CAD consortium, basic CAD consortium, and updated Diamond-Forrester models was evaluated on Prediction performance for abnormal myocardial perfusion by expert visual interpretation in external testing (AUC 0.762, 95% CI 0.750-0.774, p=<0.001). A machine learning model utilizing pre-test clinical features predicted abnormal myocardial perfusion with higher accuracy compared to the clinical CAD consortium model.
Synapse has enriched 10 related papers. Consider them for comparative context: